Tumor necrosis factor receptors 6α and 6β
US8003386B1 · kind B1 · utility
7Cited by
9References
104Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 13, 1998 |
| Grant date | Aug 23, 2011 |
| Priority date | — |
| Expiry date | Jan 31, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K14/70578
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention relates to novel Tumor Necorsis Factor Receptor proteins. In particular, isolated nucleic acid molecules are provided encoding the human TNFR-6α & -6β proteins. TNFR-6α & -6β polypeptides are also provided as are vectors, host cells and recombinant methods for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of TNFR-6α & -6β activity. Also provided are diagnostic methods for detecting immune system-related disorders and therapeutic methods for treating immune system-related disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.